These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 18848880)

  • 1. Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: A systematic comparison of their impact on cognition.
    van den Berg E; Kloppenborg RP; Kessels RP; Kappelle LJ; Biessels GJ
    Biochim Biophys Acta; 2009 May; 1792(5):470-81. PubMed ID: 18848880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [NF-kB activation as a molecular basis of pathological process by metabolic syndrome].
    Kaĭdashev IP
    Fiziol Zh (1994); 2012; 58(1):93-101. PubMed ID: 22590744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 2 diabetes, cognitive function and dementia: vascular and metabolic determinants.
    van den Berg E; Kessels RP; Kappelle LJ; de Haan EH; Biessels GJ;
    Drugs Today (Barc); 2006 Nov; 42(11):741-54. PubMed ID: 17171193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modifiers of cognitive function and brain structure in middle-aged and elderly individuals with type 2 diabetes mellitus.
    Bruehl H; Wolf OT; Sweat V; Tirsi A; Richardson S; Convit A
    Brain Res; 2009 Jul; 1280():186-94. PubMed ID: 19463794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive functioning in elderly persons with type 2 diabetes and metabolic syndrome: the Hoorn study.
    van den Berg E; Dekker JM; Nijpels G; Kessels RP; Kappelle LJ; de Haan EH; Heine RJ; Stehouwer CD; Biessels GJ
    Dement Geriatr Cogn Disord; 2008; 26(3):261-9. PubMed ID: 18841011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of obesity with hypertension and dyslipidemia in type 2 diabetes mellitus subjects.
    Anari R; Amani R; Latifi SM; Veissi M; Shahbazian H
    Diabetes Metab Syndr; 2017; 11(1):37-41. PubMed ID: 27477531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of C3 in patients with severe, morbid and extreme obesity: its relationship to insulin resistance and different cardiovascular risk factors.
    Hernández-Mijares A; Jarabo-Bueno MM; López-Ruiz A; Solá-Izquierdo E; Morillas-Ariño C; Martínez-Triguero ML
    Int J Obes (Lond); 2007 Jun; 31(6):927-32. PubMed ID: 17264851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assessment of selected markers of inflammation in patients with clinical symptoms of insulin resistance and normal renal function].
    Bogdański P; Pupek-Musialik D; Luczak M; Szulińska M
    Pol Merkur Lekarski; 2006 Aug; 21(122):165-8; discussion 169. PubMed ID: 17144103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and factor analysis of obesity, type II diabetes, hypertension, and dyslipidemia (syndrome X) on the Island of Kosrae, Federated States of Micronesia.
    Shmulewitz D; Auerbach SB; Lehner T; Blundell ML; Winick JD; Youngman LD; Skilling V; Heath SC; Ott J; Stoffel M; Breslow JL; Friedman JM
    Hum Hered; 2001; 51(1-2):8-19. PubMed ID: 11096265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for development of diabetes mellitus, hypertension and dyslipidemia.
    Fukui M; Tanaka M; Toda H; Senmaru T; Sakabe K; Ushigome E; Asano M; Yamazaki M; Hasegawa G; Imai S; Nakamura N
    Diabetes Res Clin Pract; 2011 Oct; 94(1):e15-8. PubMed ID: 21802759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity and lowered cognitive performance in a Canadian First Nations population.
    Fergenbaum JH; Bruce S; Lou W; Hanley AJ; Greenwood C; Young TK
    Obesity (Silver Spring); 2009 Oct; 17(10):1957-63. PubMed ID: 19478788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond type 2 diabetes, obesity and hypertension: an axis including sleep apnea, left ventricular hypertrophy, endothelial dysfunction, and aortic stiffness among Mexican Americans in Starr County, Texas.
    Hanis CL; Redline S; Cade BE; Bell GI; Cox NJ; Below JE; Brown EL; Aguilar D
    Cardiovasc Diabetol; 2016 Jun; 15():86. PubMed ID: 27266869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of serum gamma-glutamyltransferase to atherogenic dyslipidemia and glycemic control in type 2 diabetes.
    Zoppini G; Targher G; Trombetta M; Lippi G; Muggeo M
    Obesity (Silver Spring); 2009 Feb; 17(2):370-4. PubMed ID: 19057528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity, diabetes and cognitive deficit: The Framingham Heart Study.
    Elias MF; Elias PK; Sullivan LM; Wolf PA; D'Agostino RB
    Neurobiol Aging; 2005 Dec; 26 Suppl 1():11-6. PubMed ID: 16223549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of adipokines in formation of lipid and carbohydrate metabolic disorders in patients with cardiovascular disease].
    Kravchun P; Kadykova O; Gabisoniia T
    Georgian Med News; 2012 Dec; (213):26-31. PubMed ID: 23293229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review.
    Kloppenborg RP; van den Berg E; Kappelle LJ; Biessels GJ
    Eur J Pharmacol; 2008 May; 585(1):97-108. PubMed ID: 18395201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cognitive dysfunction and dementia associated with elderly diabetes].
    Kouta Y; Sakurai T; Yokono K
    Nihon Rinsho; 2006 Jan; 64(1):119-23. PubMed ID: 16408458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential impact of cerebral white matter changes, diabetes, hypertension and stroke on cognitive performance among non-disabled elderly. The LADIS study.
    Verdelho A; Madureira S; Ferro JM; Basile AM; Chabriat H; Erkinjuntti T; Fazekas F; Hennerici M; O'Brien J; Pantoni L; Salvadori E; Scheltens P; Visser MC; Wahlund LO; Waldemar G; Wallin A; Inzitari D;
    J Neurol Neurosurg Psychiatry; 2007 Dec; 78(12):1325-30. PubMed ID: 17470472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
    Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypothalamic-pituitary-adrenal axis dysregulation and memory impairments in type 2 diabetes.
    Bruehl H; Rueger M; Dziobek I; Sweat V; Tirsi A; Javier E; Arentoft A; Wolf OT; Convit A
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2439-45. PubMed ID: 17426095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.